Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa by Jaillard, M et al.
1 
  VERSION 14 June, 2016 
 
GENOMIC RESISTANCE GENE DETECTION, 
INTEGRON DIVERSITY MAPPING AND 
RESISTOME-WIDE ASSOCIATION ANALYSIS  
HELP DEFINE ANTIBIOTIC RESISTANCE  
IN PSEUDOMONAS AERUGINOSA 
 
 
Magali Jaillard1, Alex van Belkum1*, Kyle Cady2, David Creely1, Dee Shortridge1,  
Bernadette Blanc1, Magda Barbu2, W. Michael Dunne Jr1, Gilles Zambardi1,  
Mark Enright3, Nathalie Mugnier1, Pierre Mahé1, Christophe Le Priol1,  
Stéphane Schicklin1, Ghislaine Guigon1 and Jean Baptiste Veyrieras1 
 
 
1bioMerieux SA, 376, Chemin de l'Orme, 69280 Marcy l'Etoile FRANCE 
2Synthetic Genomics, Inc., 11149 North Torrey Pines Road, La Jolla, CA 92037, USA 
3Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK. 
 
*Communicating author:  Alex van Belkum 
 
Address for correspondence:  bioMérieux, Microbiology R&D,  
3 Route de Port Michaud,  
38390 La Balme Les Grottes, France 
e-mail alex.vanbelkum@biomerieux.com 
phone 0033609487905. 
 
Conflicts of interest: All authors except ME are (part-time) employees of bioMérieux 
or Synthetic Genomics Inc and hence have a business implication in all work 
presented here. However, the study was designed and executed in an open manner 
and all data generated have been deposited in the public domain, also resulting in 
the current publication. 
 
  
2 
Abstract 
 
Objectives: Genetic determinants of antibiotic resistance have been extensively 
investigated in the past using relatively small panels of clinical microbial isolates. 
Today, next generation sequencing allows a broader assessment of the links 
between genotype and phenotypic antibiotic susceptibility. Such large-scale 
association studies are expected to refine the present understanding of the genetics 
of antibiotic resistance.  
Methods: We analyzed 672 strains of Pseudomonas aeruginosa, including 
representatives of the major multi (MDR) and extensively (XDR) drug resistant 
clones, for which genome sequences and multiple parameter antibiograms were 
available. We correlated variability in antibiograms and minimal inhibitory 
concentrations (MICs) for those antibiotics with the occurrence of resistance genes, 
performed a search for and characterization of integrons and developed a resistome 
wide association study (RWAS) for the nine most relevant and clinically useful 
antibiotics. We distinguished intrinsic and extrinsic resistance genes and single 
nucleotide polymorphisms and insertions-deletions (indels) in such genes while 
controlling for potential confounding effects due to population structure 
Results: The complex resistome of P. aeruginosa was visualized at the population 
level and gene prevalence could be defined at the species level. The previously 
assessed intrinsic genes were identified and a large number of more mobile and less 
frequent genes were mapped. A visual representation of combined genotypic and 
phenotypic data was developed. 
Using a bioinformatics approach, integron content and variation was established 
showing 28 non-unique integron types carrying a variety of antibiotic resistance 
genes. Some of the integrons closely associated with known clonal complexes 
whereas others were more randomly distributed across the phylogenetic tree.. 
The RWAS led to the correct identification of the main known resistance mechanisms 
for meropenem, amikacin, levofloxacin and cefepime,  but also to the detection of 46 
new mutations associated with an increase or decrease of MIC for meropenem, 
amikacin, cefepime and colistin antibiotics. Among these new candidates, 29 were 
variants of the oprD gene and these associated with variation in the meropenem 
MIC.  
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Conclusions: The results shown here for P. aeruginosa validated different statistical 
association frameworks based on which MIC and resistome-wide data could be 
correlated. We developed a system for integron mapping and characterization using 
genome sequences. The same approaches can be applied to other microbial species 
ultimately facilitating the prediction of an antibiogram on the basis of genomic 
resistance gene content. 
 
Key words: Antibiotic resistance – Pseudomonas aeruginosa – RWAS – integrons – 
resistance gene mapping 
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Introduction 
 
Pseudomonas aeruginosa strains have large genomes with a degree of plasticity 
allowing adaptation to a diversity of pathogenic and natural environments. The 
species is genetically variable due to efficient recombination and acquisition of 
mobile genetic elements (MGEs) [42]. P. aeruginosa absorbs exogenous DNA and 
under selective antibiotic pressure it efficiently gathers resistance traits [33, 43]. 
Accumulation of resistance traits is more likely to occur in isolates with enhanced 
virulence [3, 34], during infection and treatment, and hence P. aeruginosa selectively 
evolves resistance to antibiotic-mediated killing [10]. In spite of the significant genetic 
variability within the species, resistant clones that spread globally have been 
identified [103, 104, 105]. Among them, multi- and extensive- drug resistant (MDR 
and XDR) clones are common, often related to the expansion of the content of 
integrons [44]. These pandemic clones include the highly prevalent sequence types 
ST235, ST111, ST348 and ST175 [13, 14, 17, 35].  
In the field of antibiotic resistance (AR) and susceptibility testing (AST) [38], progress 
needs to be made for better delineation of existing and novel AR mechanisms and 
resistance genes [106]. Genome sequencing of P. aeruginosa libraries identified 
molecular markers for resistance to amikacin, meropenem and levofloxacin [30]. 
Additionally, the international P. aeruginosa consortium published a summary of the 
species’ resistome, recognizing 73 known AR genes in 389 isolates and highlighting 
the importance of the accessory genome in overall antibiotic resistance [41]. Our 
recent studies revealed that there may be differences in the resistome of strains 
equipped with different CRISPR-Cas bacterial immune systems [99]. However, 
CRISP-Cas immunity does not seem to be directly blocking the acquisition of 
resistance elements, although the CRISPR spacers do possess a small number of 
target sequences against known plasmids that may carry resistance elements 
themselves [99]. Hence, additional studies on resistance gene content of the P. 
aeruginosa pan-genome are still much needed. 
Studies for other pathogens have suggested that genomic antibiograms can perform 
as well as phenotype-based techniques. The first large study in this field documented 
99.7% concordance between geno- and phenotypic antibiograms [27]. Subsequent 
work on Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and 
Campylobacter spp confirmed and extended these findings [28, 29, 108], whereas for 
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a strictly clonal bacterial species such as Mycobacterium tuberculosis very 
impressive results were obtained [107]. A recent resistome analysis for P. aeruginosa 
correlated meropenem resistance with outer membrane protein OprD polymorphism 
but other factors including metallo-beta-lactamases and Klebsiella pneumonia 
carbapenemases played important roles as well [30]. Levofloxacin resistance was 
found to primarily depend on QRDR variation in DNA gyrase and topoisomerase 
mutations. Amikacin resistance was mostly associated with efflux systems and the 
presence of aminoglycoside modifying enzymes. Clearly, genomic approaches hold 
promise for the development of future AST systems for routine use in clinical 
microbiology laboratories, although knowledge gaps still need to be filled. In order to 
precisely predict resistance or susceptibility from a genome minimum standards for 
genome coverage, assembly and annotation need to be agreed upon prior to its 
widespread use in routine diagnostics [109]. 
Here we present a genome-based resistome characterization, a descriptive study of 
integron dynamics and a resistome-wide association study for 672 P. aeruginosa 
strains for which the complete genome sequence was known and for which MIC 
values for the 9 most often used anti-P. aeruginosa antibiotics were available.  
 
 
Materials and methods 
 
Description of the strain panel: Genomic information for 672 P. aeruginosa strains 
was analyzed. Strains were obtained from 3 diverse collections: the bioMérieux 
collection (n=219) [99], the Kos collection (n=390) (30), and the Pirnay collection 
(n=63) [110]. Strains were identified to the species level based on the use of VITEK2 
ID 32 A identification cards and API analyses and, if needed, specific sequencing of 
16S rRNA and EF-Tu genes (results not shown). Genome sequences were obtained 
as previously reported [30, 99, 110] and assembled and annotated for the 
identification of core and variable genes. Genomic MLST and phylogenetic 
comparisons were performed. For the strains in the Pirnay and bioMérieux 
collections, reference antibiotic resistance data based upon broth dilution assays 
complemented with VITEK2 data were available for more than 20 antibiotics for most 
strains. In addition, a public database including resistance testing and genome 
sequences was retrieved for 388 P. aeruginosa isolates of the Kos collection since 
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two isolates were not tested for antibiotic resistance [30]. Resistance data included 
results for meropenem, amikacin and levofloxacin. More detailed information on all of 
the strains and their analyses can be obtained from recently published work [99].  We 
have now developed a database including information on the nine antibiotics 
included in this study (Supplementary Table XX??).   
Resistome: The resistome of the 672 P. aeruginosa isolates was obtained by 
annotating each genome assembly versus an in-house pan-bacterial antibiotic 
resistance sequences database. This database contains 2545 non-redundant 
reference sequences categorized into 569 antibiotic resistance (AR) genes. More 
specifically, among these reference sequences, the database contains at least one 
sequence for each previously reported AR gene including genes directly involved in 
susceptibility and/or resistance per se in P. aeruginosa [33]. 
Each genome was then searched via BLASTn (Version 2.2.28+) for resistance genes 
with at least 80% identity and at least 80% coverage relative to at least one gene 
within our 569 gene library. Overlapping alignments belonging to the same AR gene 
were clustered into a single hit if the overlap covered more than 10% of the aligned 
reference sequences. For each cluster, we only kept the best hit defined as the 
alignment with the highest percentage identity times the reference sequence 
coverage. This best hit was retained to infer the haplotype state of the gene (e.g. if 
the best hit was obtained with the reference sequence of OXA-31, we annotated the 
gene as an OXA-31 variant). Note that for a given isolate and for a given AR gene 
several distinct annotations (i.e. distinct copies) can be reported when hits appeared 
at distinct genomic locations. Supplementary Table 5 reports the genotypes (copy 
number of genes and allelic doses of mutations) of each of the 147 determinants that 
were found at least once among the 672 genomes. 
Integron analyses: We detected integrase genes by aligning (tblastn) the 
assembled genome sequences (in all reading frames) with the protein sequences of 
the three known integrases: intI1, intI2 and intI3 as derived from a targeted UniProt 
search. The integrase sequences used to annotate the strains are provided in 
Supplementary File 1. Contrary to intl1 for which we were able to retrieve 36 
reference sequences, we found only 3 reference sequences for intI3 and only 1 
reference sequence for intI2. We used the same strategy that was used for the 
antibiotic resistance gene annotation with a 70% identity and 70% protein coverage 
cutoff. We then searched for recognizable and annotated AR genes upstream of the 
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integrase start codon and reported the physical distance between the integrase start 
codon and the 5’ end of the resistance element. We included all resistance elements 
within a 10 kb window thereby assuming that all resistance elements being part of 
the integron would thus be found.  
Resistome genotyping: Based on our resistome annotations, we genotyped the 672 
isolates for allele counts at both the “locus-level” and the “variant-level”. By allele 
counts at the locus level we mean the distinct number of copies of a given AR gene 
(e.g. TEM, mexX, etc) irrespective of the alleles of the gene. Regarding the allele 
counts at the variant-level, we aligned all the detected sequences of a given AR gene 
using mafft (version 6.861 using high-precision mode see reference [100]) in order to 
identify both SNPs including tri- and quadri-allelic sites and indels. Finally, for a given 
isolate, we counted the number of occurrences for each SNP and indel allele and 
used this as the corresponding allele count at the variant-level. 
Resistome-wide association study (RWAS): Our objective here was two-fold: we 
first assessed the strength of association between causal genotypes known to 
increase (or decrease) the MIC value (generally beyond the resistance breakpoint) 
and, second, we looked for novel candidate genotypes that may be associated with 
an additional variability of MIC values taking the effect of known genotypes into 
account. Figure 1 provides a literature-derived overview of the causal genes or 
variants thereof known to increase (or decrease) the MIC value for each antibiotic in 
our association study.  
Population structure: Association results may be inflated by the presence of cryptic 
correlations between population structure and the MIC status of the strains. This 
could be due to either population-wide linkage disequilibrium (LD) between the 
causal mutations and the genetic structure, or to a sampling bias leading to over-
representation of related strains. We prevented confounding effects due to population 
structure by computing the principal components (PC) from the isolate covariance 
matrix derived from the non-resistome related core-SNP genotypes [53]. By “non-
resistome related” we mean that we removed SNPs from core-genes that are also 
part of our resistome database (gyrA, gyrB, parC, parE, folP, OXA-50, ampC, etc) 
and that were subsequently evaluated for association with the MIC values. The PC 
scores of the isolates have been used as covariates in the statistical association 
framework.  
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Associative modeling: For each antibiotic we used ordinal regression [45] to 
develop the core statistical association framework. This provides the benefit of 
adequately accounting for the ordinal nature of the MIC values and it facilitates 
inclusion of covariates into the association model, in order to both control for 
population structure, and to test for the additional predictive value of genotypes with 
respect to known causal genotypes.  
For each antibiotic we first forwardly included any principal components (PC) with a 
p-value of 0.05 or less as covariates into the ordinal regression model. We thus built 
Z, the n x k matrix of PC where n is the number of isolates with a non-missing MIC 
value and k the number of retained PC after the forward inclusion procedure. After 
the inclusion of the PC as covariates, we added all known genotypes to the retained 
model. Considering only known genotypes as eligible, we then performed a 
backward elimination procedure based on the Akaike Information criterion (AIC) and 
stopped when any removal of a known genotype increased the AIC with respect to 
the previous model [101]. By doing so, we intended to select the optimal subset of 
known causal genotypes associated with MIC variability while preserving statistical 
power for detecting new associations. This step led to a matrix U of size n x p, of 
genuine causal genotype counts where p is the number of genotypes retained after 
the backward elimination procedure. Finally, we evaluated novel candidate 
genotypes for locus- and variant-allelic counts. These tests were performed 
independently for each candidate genotype x. If we denote Yi the MIC values for 
isolate i=1..n assuming that Yi can fall into j=1..J ordered categories (from the lowest 
tested antibiotic concentration to the higher one), we then considered the following 
cumulative link model for each candidate P ( Yi ≤ j ) = πi1 + … + πij, where πij for 
j=1..J denotes the probability that the ith observation falls in the jth MIC category. Our 
cumulative logit regression model is then:  
 logit[ P( 𝒀𝒊 ≤ 𝒋 ) ] = log [
P ( 𝒀𝒊 ≤𝒋 )
𝟏−P ( 𝒀𝒊 ≤𝒋 )
] 
                            = θj − ( Zα + Uβ + xγ)   
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where : { ϴj } for j=1..J stands for the MIC category intercepts, α is the vector of k 
regression parameters for the PC scores capturing the genetic structure, β is the 
vector of p regression parameters for the known causal genotypes, and γ is the 
regression parameter for the candidate genotype x. 
To compute the p-value of the association between the candidate genotypes and the 
MIC variability, we used the standard likelihood-ratio test (LRT) [102]. This test 
compares the log-likelihood of the ordinal regression model under the null hypothesis 
(H0: the genotype has no effect on MIC variability; γ = 0) versus the alternative 
hypothesis (H1: the genotype has an effect on MIC variability; γ ≠0). If we denote  
L0(ϴ, α, β; Y) and L1(ϴ, α, β, γ; Y)) the log-likelihoods under each hypothesis, we 
can derive the likelihood-ratio test formula: -2 [ L1 – L0 ] ~ ² and compute the 
association p-value of each tested genotype from this formula. 
Finally, we reported significant associations by controlling the false-discovery rate for 
each antibiotic at 5% using the Benjamini and Hochberg procedure [46]. We used the 
R package ordinal (R Development Core Team, 2011) to implement our cumulative 
logit regression framework. 
 
 
Results 
 
Global resistome and association analysis for known resistance markers: We 
assembled antibiogram data for 672 isolates, however, our analysis focused only on 
the 9 most clinically relevant drugs belonging to 6 main families: aminoglycosides 
(amikacin), beta-lactams (meropenem, cefepime and piperacillin), quinolones 
(levofloxacin), polypeptides (colistin and polymyxin B), fosfomycins (fosfomycin) and 
phenicols (chloramphenicol) (Supplemental Table 4). Resistome analysis identified 
147 loci previously suspected or confirmed to provide resistance to these major 
antibiotic families (see Figure 1, left column) . While most resistance elements were 
found to be extra-chromosomal, 45% of AR elements were chromosomally encoded. 
Note that we did not specifically address locations on MGEs or plasmids. The 147 
AR elements cover 5 mechanisms to neutralize antibiotic action, involving both 
intrinsic and acquired resistance traits. Figure 1 also shows the population structure, 
phenotypic resistance markers and genome size variability and confirms that  
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resistance related to drug efflux and the activity of enzymatic pumps is mainly 
intrinsic. Traits dealing with antibiotic inactivation are mainly acquired. 
Integron analyses: Integrase genes were found in one third of isolates (n=229), and 
an AR gene was identified upstream of two thirds of these integrase motifs (n=163). 
Interestingly, only class 1 integrons were detected in the current study. Thirty-seven 
different resistance genes were found to be co-localized with the integrase, and were 
therefore identified as being integron associated. OXA and sul1 were found to be the 
most frequent AR genes: among the 163 integrons carrying AR genes, only 17 did 
not carry OXA nor sul1 genes. Class I integrons are known to carry a large variety of 
resistance genes, particularly those targeting phenicol, aminoglycoside or beta-
lactam antibiotics [42, 43]. In particular, there are known to encode aminoglycoside 
modifying enzymes, adenylytransferases and acetyltransferases [39, 40, 42, 43]. We 
found these gene families to be enriched in the P. aeruginosa integrons, as shown by 
the Poisson distribution test result in Figure 2A: enrichment is defined as a higher 
proportion of gene found in integron compared to other genome location, and is 
shown by a star. Over these 14 genes which are significantly more frequent within 
the 10kb upstream region of int1, 11 belong either to the adenylytransferase (aad) or 
acetyltransferase (AAC) gene families  
Seventy-two different AR gene combinations were identified in the integrons of which 
the most prevalent one occurred 27 times and only contained the sul1 and aadA6 AR 
genes. This cassette was identified as the In51 integron [39], containing, ordered 
from the integrase Intl1: aadA6, orfD, qacE1 and sul1 genes. Three isolates carried 
a truncated form of In51, with either a deletion within the antiseptic resistance gene 
qacE1 or complete deletion of the orfD gene, as shown in Figure 2B. 
Figures 2C and 2D highlight the great diversity of integron cassettes, by showing the 
AR gene combinations found more than 3 times (Figure 2C) and their variable 
distribution along the phylogenetic tree (Figure 2D). Thus we can observe integrons 
which are specific to small clades, such as the one carrying AR cassettes #2, #3, #14 
or #15 and integrons that spread among all phylogroups, such as the one carrying 
AR cassettes #1 (In51), #4 or #7. Obviously, such analyses identify physically-
associated resistance traits and generate evidence of horizontal transfer between 
distantly related strains. 
Correlating geno- and phenotypes through RWAS: We carried out a detailed 
association study for the 9 major clinically used antibiotics and the combined 
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phenotypes (MIC values) and genotypes (copy number of genes (Figure 3A) and 
allelic doses of mutations - both SNPs & INDELs - within each gene (Figure 3B)) for 
all isolates using ordinal regression. Results are summarized in Figure 3 where both 
known and new associations are reported. Around 15% of the known determinants 
were not found to be associated because they were only present once or twice 
among all isolate genomes. Our test had not enough statistical power to detect these 
variants with extremely low allele frequencies. This concern 17 genes, shown on the 
left side of Figure 3A (the occurrence number within the 672 genomes is given below 
each gene column) and some mutations in gyrA and gyrB genes, e.g.  gyrB:467/468 
is present only once in the panel. 
Very low prevalence of a particular resistance status also prevents from detecting 
significant associations. In Figure 3, antibiotic rows are ordered by decreasing 
prevalence; polymyxin B, colistin and chloramphenicol all present prevalence of non-
sensitive isolates below 3%: 3 non-sensitive among 117 isolates for polymyxin B, 15 
non-sensitives among 524 isolates for colistin and 3 sensitives among 103 isolates 
for chloramphenicol (see Supplementary Table 1). This may explain the absence of 
significant associations between known genotypes and MIC values for these 3 
antibiotics. However, thanks to a large sample size available for colistin (n=524), 
conversely to the low sample size for polymyxin B and chloramphenicol, we found 
two new associations for this drug. First, the absence of the mexS gene (efflux pump) 
in 24 isolates yields an increased susceptibility: 50% of the isolates without mexS 
exhibit a MIC value less than 0.5ug/ml. This is in contrast with recent analyses where 
no such correlation was found [111]. Second, a deletion of the 5’end of the ampD 
gene (which varies in size in our panel up to 70 bp from the 5’end, although to avoid 
redundancy we reported it as a single indel in Figure 3) observed in 12 isolates 
seems to be related to an increase of the MIC values of these isolates (60% of them 
have a MIC value greater than or equal to 2 g/ml, with respect to 3% for the 512 
isolates with the non-deleted version of ampD, see Supplementary Figure 4). 
The lack of statistical power due to a limited number of isolates with MIC values may 
explain the negative results for fosfomycin (n=113 and 36 resistant isolates). More 
surprisingly, no significant association was observed for piperacillin (n=280 and 114 
resistant isolates). There is no strong population structure that could explain these 
poor results (see Supplementary figure 11). 
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For cefepime, we confirmed the association with the presence of OXA but due to the 
low frequency of the gene AER (2 occurrences in our panel), we were unable to 
further test the association between the latter gene and cefepime susceptibility. 
Interestingly, we found cefepime resistance associations with OXA mutations which 
suggest that specific alleles of OXA correlate with higher MIC values (in particular 
mutations related to haplotypes OXA-31 and OXA-224, see also Supplementary 
Figure 5) [112].  
Most of the known resistance genotypes for levofloxacin were found to be 
significantly associated with the MIC values (except the presence of AAC(6’)-Ib3, and 
some mutations in gyrA and gyrB, for which the frequencies in our panel were too 
low). The two common non-synonymous mutations gyrA:T83I (38% of the isolates) 
and parC:S87L (26% of the isolates) show the highest association scores (p-value = 
1.29x10-61 and 3.52x10-40, respectively). No additional association was detected. 
Regarding amikacin, 9 out of the 26 genes (mostly the AAC(6’) family)  known to 
confer resistance were found to be statistically significantly associated with elevated 
MICs. Among the 17 undetected genes, 7 show extremely low allele frequencies. 
Regarding new associations, isolates lacking the efflux pump genes, mexX (10 
isolates) and mexY (14 isolates), tend to exhibit lower MIC values: in both cases 
around 50% of the mexX/mexY deleted isolates have MIC values lower or equal to 
0.5ug/ml (see Supplementary Figure 2A). Surprisingly, gyrA:T83I absence or 
presence is strongly associated with the amikacin MIC values, suggesting either a 
joint selective pressure for resistance to levofloxacin and amikacin or a sampling bias 
in our panel where closely-related MDR isolates could be over-represented. The 
association with the presence of OXA gene is likely also to be an artifact since OXA 
genes are a proxy of resistance cassettes linked to class I integrons (as discussed 
previously). This may suggest the presence of additional resistance genes (e.g. rare 
variants of AAC(6’) genes) within the integron cassette not adequately detected by 
our current annotation pipeline.  
Six out of the 23 known genotypes for meropenem resistance showed a statistically 
significant association, in particular for the presence of beta-lactamases VIM, VEB, 
OXA, KPC and IMP (whatever the allelic state of these genes). Here again, 7 out of 
the 17 undetected genes were not detectable due to extremely low allele 
frequencies. Despite high allele frequencies we did not document significant 
associations for CARB, GES and PER. The absence of the porin gene oprD (about 
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4% of the tested isolates) was also confirmed as significantly associated with 
increase in MIC values: 75% of the isolates lacking oprD show MIC values ≥ 8 when 
only 25% of isolates with oprD reach such value (see Supplementary Figure 8a). 
Regarding new associations for meropenem, gyrA and parC non-synonymous 
mutations related to levofloxacin resistance were also identified. The same 
assumptions as for amikacin resistance associated to gyrA mutation may apply here. 
Interestingly, several mutations within the porin gene oprD showed a significant 
association signal with meropenem MIC variability. Most of them are in strong 
linkage-disequilibrium (see Figure 3): by clustering mutations with a LD of at least 0.8 
(as measured using r-squared), we can distinguish 6 groups among which 3 
singletons and 1 group with only two linked mutations. The first singleton is the 
mutation leading to an early-stop codon at the beginning of the gene (oprD:Q18* in 
Figure 3) carried by 38 isolates in our panel for which the minimal MIC value was 
0.25ug/ml and 60% of the 38 isolates have a MIC >8ug/ml.  
Another early-stop codon, oprD:K350*, a singleton slightly linked to oprD:Q18*, was 
detected at the end of the gene and observed in 28 isolates, leading to a similar 
increase of the MIC values as for oprD:Q18*.  
Conversely, the two linked synonymous mutations (oprD_180_c and oprD_758_a in 
Figure 3) are associated with more susceptible isolates (60% of them have a MIC 
value ≤ 0.25 while this proportion falls to 25% for alternative genotypes). The fact that 
these mutations do not result in changes to the protein sequence may suggest that 
they are in LD with a non-identified causal mutation elsewhere.  
The two other groups of linked mutations, where both non-synonymous and 
synonymous mutations were observed, are more difficult to interpret and seem to 
generate both more susceptible and more resistant isolates, resulting in a skewed 
distribution of MIC values. Although statistically significant within our ordinal 
regression framework, this suggests that these latter mutations are not directly 
associated with a change in the MIC values but rather with a specific group of oprD 
haplotypes. In examining efflux pump genes associated to meropenem resistance, 
we found a frameshift mutation within mexZ, - “mexZ_489_−” (Figure 3) carried by 12 
isolates among which 10 have a MIC value >8ug/ml. Surprisingly, this frameshift 
correlates with an increase in MIC which appears unexpected. In the same way, but 
to a weaker extend, the early stop mutation found in mexX (mexX:Q395*) observed 
in 8 isolates correlated with a slight increase in the MICs of those isolates. 
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Conversely, the synonymous mexD mutation (mexD_1752_c)  observed in 6 isolates 
was found to be associated with a decrease in MIC. All these results in efflux pump 
genes must be treated with caution since the mutation frequencies are quite low. 
Finally, we identified a non-synonymous mutation in ampO - ampO:P287H (Figure3), 
yielding to a decrease in MIC values for the 6 isolates carrying this genotype. All 
associations results are listed in Supplementary Tables 2 and 3). 
 
Discussion 
The susceptibility of a microbial pathogen to therapeutically relevant antibiotics is one 
of the clinically most relevant bacterial phenotypes. Genome sequences have 
already been shown to confirm existing and facilitate the discovery of new resistance 
traits [7, 9]. Huge databases have been developed that contain more or less 
complete inventories of all genetic factors known to be involved in antimicrobial 
resistance. The format of such database may differ and some of them are 
accompanied by specific software packages that facilitate aimed searches for 
resistance genes in genome sequences or metagenomic databases [113, 114, 115, 
116, 117]. Tools such as these are relatively new and still need specific testing for 
the various bacterial species. We here focus on P. aeruginosa and its MDR and XDR 
clones as a model bacterial species and defined the genomic polymorphisms 
associated with antibiotic (multi-)resistance. In particular, oprD was confirmed as an 
important meropenem AR gene. Globally, our analyses confirm the correlation 
between MICs and most of the known resistance traits if these occur in sufficient 
frequency in our strain panel. Our statistical framework made it possible to explore 
even more detailed associations by controlling for the already established  
correlations. Moreover, all association studies were strictly controlled for population 
structure via a principal component driven approach based on a calculation of core 
SNP co-variances. As such the approach presented here is fully bacterial species’ 
independent and new mutations, including ones involved in genetic control rather 
than being directly causal, can be discovered. This was illustrated here by the 
mutations found within oprD, in particular the two mutations leading to an early stop 
codon and associated with an increase of meropenem MICs. 
Intrinsic resistance is an important and extensive phenotype for P. aeruginosa [120]. 
It’s genomic markers are many and diverse and gaining additional insight in the 
intrinsic resistance gene array is still important and clonal complexes may be helpful 
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in delineating full intrinsic resistomes. Recently, the first genome sequences of 
representatives of the P. aeruginosa MDR clone ST111 were reported [25]. 
Comparative analysis of these sequences with regard to genes involved in antibiotic 
or antiseptic resistance revealed key resistance mutations in a variety of well-known 
genes. The authors suggested that rapid mapping of the polymorphisms detected 
could be used for optimization of antibiotic choice. Similar data for ST235 became 
available and genomic islands 1 and 2 were shown to be important in the dynamics 
of resistance development. Class 1 integrons, already before shown to often carry 
metallo-beta-lactamase genes [119], were identified as important elements and 
integration and conjugation as important evolutionary processes facilitating 
resistance flexibility [121]. Even more recently a detailed study described the 
successful detection of presumptive ceftazidime resistance markers in 88% of all P. 
aeruginosa genomes studied [118]. Here we successfully introduce a method that 
does not only allow for monitoring resistance but which is even able to categorize 
strains on the basis of elevated MICs, even below the clinically relevant resistance 
level. In the context of elevated LD causing “statistical fog” we are still able to exploit 
the sequence information collected and identify mutations that correlate well with the 
MIC distribution. This allows for the identification of mutations which in themselves do 
not cause resistance but which, when accumulating over time, may still result in 
clinical resistance. This generates information on the emergence and evolution of 
new haplotypes that may even further accumulate mutations. It may also help 
understand the mechanisms of resistance development including genetic control and 
regulatory feedback loops. More than the validation of known mechanisms, the 
resistome-wide association study allowed to highlight new candidates, such as 
mexX/Y efflux pump for amikacin) together with the importance of the allelic form of 
accessory genes in correlation with MIC increase or decrease (oprD forms in 
meropenem resistance and OXA forms in cefepime resistance). This study also 
illustrated some limits in a single isolate panel constitution for multi-drug testing: low 
sample size (around 100 isolates), low prevalence of a resistance status (below 3%) 
and very low allele frequencies prevent from detecting good associations, due to a 
lack of statistical power. 
Additional analyses using phenotypically well-defined and genetically diverse as well 
as ST-identical strains need to be performed in order to validate our initial findings. 
When this has been done we may then move towards real genome-wide association 
16 
studies (GWAS) without the strict need for a reference genome, which would 
otherwise be quite restrictive for highly plastic species such as P. aeruginosa. Such 
methods may further detail genotype-phenotype associations but care must be taken: 
what works well for clonal species may still be difficult for species with an a more 
panmictic population structure. A realistic assessment of feasibility must be done, 
way before thinking of introducing such methods in the routine microbiology 
laboratory. 
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FIGURE LEGENDS 
 
Figure 1. Overview of the phenotypic, genomic and resistome data of the 672 P. 
aeruginosa isolates included in the present analysis. The phylogenetic tree is 
inferred from core-gene content and depicts the 3 major groups of P. aeruginosa in 
shades of purple. Depicted below the tree in dark green bars, are the isolates which 
were found resistant to one or more of  the 9 antibiotics analyzed in this study. Below 
this part of the graph, strains with genomes larger or smaller than the median are 
depicted as black or grey, respectively. The left panel provides the names of genes 
and non-synonymous mutations constituting the resistome for the 9 key antibiotics. 
Different antibiotic resistance mechanisms are color coded (bar to the right of the 
gene and mutation list). The right box reviews gene content on a per isolate basis 
and endogenous resistance markers can be easily distinguished from the acquired 
ones by gray shading. The resistome structure defines core (45%) versus accessory 
(55%) resistance elements, where it is obvious that antibiotic inactivation genes are 
more likely to belong to the accessory resistome than efflux genes. Note that 
resistance genes embedded in integrons are color coded as dark red bars. The 
percentages on the far right define gene prevalence across the entire group of 
strains. 
 
Figure 2. Class-I integron composition analysis for P. aeruginosa. Since only 
Intl1 sequences were detected in our panel, only class-I integrons are reported. 
Panel A depicts the integron frequency of occurrence (34.1% in our case) in the 
isolates analyzed and assesses the AR content of putative integrons by searching for 
resistance genes up to 10kb upstream of the Intl1 motif. The resistance genes were 
tested for enrichment in integrons compared to alternative genome locations. Panel B  
further identify the order of the genes and their individual frequency of occurrence for 
the main integron cassette, In51. Panel C depicts the different configurations (in 
terms of AR gene composition) of the most frequent Intl1 integrons, with the most 
frequent one (n=27) containing sul1 and aadA6 AR genes only. Panel D shows their 
presence in the different clonal P. aeruginosa clusters as present in the phylogenetic 
tree. Note that some integron types cluster according to bacterial sT, whereas others 
are more widely scattered throughout the phylogenetic tree. 
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Figure 3. – Synoptic representation of the Resistome Wide Association Study 
(RWAS) results. Only genes and mutations either known to be associated or 
subsequently found to be associated with resistance against the 9 antibiotics tested 
here are displayed. Panel A provides the results for the presence versus absence of 
genes while panel B focuses on specific mutations within genes. Genes and 
mutations are reported on columns and antibiotics in rows. Note that rows were 
ordered by decreasing phenotype prevalence, and in panel A, columns were ordered 
by increasing allele frequency. In both panels, an empty cell in the table means that 
no association was found. Green cell indicates that a significant new association has 
been detected. Dark or light red cell stands for a known determinant  found to be 
significantly associated with MIC variability. Only determinants whose cells are filled 
with dark red have been retained by our backward-elimination procedure to test for 
new associations. Conversely, dark or light blue cell stands for known determinants, 
but these are not significantly associated with the MIC variability in our panel of 
strains. Nevertheless some of these determinants (whose cells are filled with dark 
blue) were retained by our conservative backward-elimination procedure (see 
Material and Methods). Finally, the nature of the mutation is color coded on the top of 
panel B. The bottom panel represents the extent of linkage disequilibrium (LD) 
between mutations.  
 
 
